You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ID recurrences

Showing 1 - 25 of 1,013
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BPPV, Benign Paroxysmal Positional Vertigo, Vertigo Trial (vitamin D +/- calcium, Placebo)

Not yet recruiting
  • BPPV
  • +7 more
  • vitamin D +/- calcium
  • Placebo
  • (no location specified)
May 8, 2023

Adolescents From Families With Intellectual Disabilities

Not yet recruiting
  • Behavioural Problems
  • Multisystemic therapy
  • Multisystemic therapy - intellectual disabilities
  • Halsteren, Netherlands
  • +2 more
Sep 4, 2023

Vaccination; Infection, COVID-19 Trial (Comirnaty)

Not yet recruiting
  • Vaccination; Infection
  • COVID-19
  • Comirnaty
  • (no location specified)
Aug 4, 2023

Down Syndrome, Intellectual Disability Trial in Paris (Biological samplings)

Recruiting
  • Down Syndrome
  • Intellectual Disability
  • Biological samplings
  • Paris, France
    Institut Jérôme Lejeune
Mar 1, 2023

Iron-deficiency, Iron Deficiency Anemia, Iron Deficiency (Without Anemia) Trial in Wilkes-Barre (Partially hydrolyzed guar gum +

Completed
  • Iron-deficiency
  • +2 more
  • Partially hydrolyzed guar gum + bifidobacterium lactis
  • +2 more
  • Wilkes-Barre, Pennsylvania
    King's College
Aug 30, 2023

Phototherapy Complication, Photobiology, Light Treatment; Complications Trial in Copenhagen (Violet-Blue Light Treatment /

Not yet recruiting
  • Phototherapy Complication
  • +4 more
  • Violet-Blue Light Treatment / FlashHeal Device
  • Copenhagen, Northwest, Denmark
    Danish Wound Healing Center, Bispebjerg Hospital
Feb 20, 2023

Insomnia Disorder Trial in Xi'an (transcranial magnetic stimulation)

Recruiting
  • Insomnia Disorder
  • transcranial magnetic stimulation
  • Xi'an, Shaanxi, China
    Xijing Hospital of Air Force Military Medical University
Aug 7, 2023

Gastrointestinal Neuroendocrine Carcinoma Trial in Beijing (Durvalumab and Chemotherapy(oxaliplatin and capecitabine))

Recruiting
  • Gastrointestinal Neuroendocrine Carcinoma
  • Durvalumab and Chemotherapy(oxaliplatin and capecitabine)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 1, 2023

Peritoneum Cancer, Peritoneal Carcinomatosis, Peritoneal Metastases Trial in Odense (PIPAC)

Recruiting
  • Peritoneum Cancer
  • +3 more
  • Odense, Denmark
    Odense PIPAC Center, Department of Surgery, Odense University Ho
Oct 5, 2022

Kidney Transplant; Complications, CMV Trial (Letermovir 480 mg once daily, Historical/Control)

Not yet recruiting
  • Kidney Transplant; Complications
  • CMV
  • Letermovir 480 mg once daily
  • Historical/Control
  • (no location specified)
Aug 14, 2023

Atrial Fibrillation Recurrent Trial in Roma (Atrial fibrillation ablation)

Recruiting
  • Atrial Fibrillation Recurrent
  • Atrial fibrillation ablation
  • Roma, Italy
    Fondazione Policlinico Agostino Gemelli Roma IRCCS
Mar 23, 2023

Exploration of Locally Recurrent Colorectal Cancer

Recruiting
  • Locally Recurrent Colorectal Cancer
  • salvage surgery
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences & Peking Un
Oct 28, 2023

Iron Deficiency and TTG Normalization

Completed
  • Celiac Disease in Children
  • Gluten free diet
  • Kfar Saba, Israel
    Meir medical center
Jan 10, 2023

Cholecystitis, Acute Trial in Pamplona (Endoscopic treatment group (EUS-GBD group)

Recruiting
  • Cholecystitis, Acute
  • Endoscopic treatment group (EUS-GBD group
  • Pamplona, Navarra, Spain
    Hospital Universitario de Navarra
Jan 18, 2023

Type 2 Diabetes (T2D) Trial in Maseru, Basel (T2D care package, Referral to the responsible health facility)

Not yet recruiting
  • Type 2 Diabetes Mellitus (T2D)
  • T2D care package
  • Referral to the responsible health facility
  • Maseru, Lesotho
  • +1 more
Feb 14, 2023

Post Operative Pain Trial in Mikkeli (Lichtenstein hernioplasty vs TEP hernioplasty)

Not yet recruiting
  • Post Operative Pain
  • Lichtenstein hernioplasty vs TEP hernioplasty
  • Mikkeli, Finland
    Mikkeli Central Hospital
May 8, 2023

Intellectual Disability Trial in Kaohsiung

Not yet recruiting
  • Intellectual Disability
    • Kaohsiung, Taiwan
      Dept of Occupational Therapy
    Jul 21, 2022

    Prostate Tumors Trial in Rochester (MR-guided cryoablation)

    Recruiting
    • Prostate Tumors
    • MR-guided cryoablation
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 9, 2023

    Rectal Cancer, Recurrence, Radiation Toxicity Trial in Aarhus, Oslo (Hyperfractionated external beam radiation)

    Completed
    • Rectal Cancer
    • +2 more
    • Hyperfractionated external beam radiation
    • Aarhus, Denmark
    • +1 more
    Apr 14, 2023

    Buccal Mucosa Cancer, Squamous Cell Carcinoma Trial (Ultrasound-guided resection)

    Not yet recruiting
    • Buccal Mucosa Cancer
    • Squamous Cell Carcinoma
    • Ultrasound-guided resection
    • (no location specified)
    May 1, 2023

    Omitting Axillary Surgery in Breast Cancer Isolated Chest Wall

    Recruiting
    • Breast Cancer
    • Recurrent Disease
    • axillary surgery
    • Singapore, Singapore
      KK Women's and Children's Hospital
    Oct 12, 2023

    Lung Cancer ID (Identity) Study

    Not yet recruiting
    • Lung Cancer Stage IV
    • Advanced lung cancer patients' group
    • Roma, Italy
    • +1 more
    Oct 4, 2023

    Inclusion, Social Trial in Berlin (Inclusive events)

    Recruiting
    • Inclusion, Social
    • Inclusive events
    • Berlin, Germany
      German University of Health and Sport
    May 12, 2023

    Intellectual Disability Trial run by the National Institutes of Health Clinical Center (CC) (TSA2 Thermosensory Stimulator)

    Recruiting
    • Intellectual Disability
    • TSA2 Thermosensory Stimulator
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Obesity Trial in Hong Kong (Adapted physical activity)

    Completed
    Has Results
    • Obesity
    • Adapted physical activity
    • Hong Kong, China
      Hong Kong Bapist University
    Apr 12, 2022